Access Wall Street consensus at a glance on our platform. Analyst ratings, price target distributions, and sentiment analysis to understand professional expectations for any stock. Aggregate analyst opinions for a consensus view. The Oncology Institute (TOI) has recently demonstrated resilience, with shares advancing 2.44% to $4.20 in the latest session. This upward movement brings the stock closer to its resistance level near $4.41, while support remains established around $3.99. Trading activity has been characterized by m
The (TOI) Rallies +2.44% as Bulls Target $4.41 2026-05-20 - Crowd Entry Signals
TOI - Stock Analysis
4711 Comments
1902 Likes
1
Meshalia
New Visitor
2 hours ago
As a detail-oriented person, this bothers me.
👍 201
Reply
2
Shawnah
New Visitor
5 hours ago
If I had read this yesterday, things would be different.
👍 45
Reply
3
Lukaus
Returning User
1 day ago
Join a US stock community sharing real-time updates, expert analysis, and strategies designed to minimize risks and maximize long-term returns. Our community members benefit from collective wisdom and shared experiences that accelerate their investment success.
👍 168
Reply
4
Rawson
Elite Member
1 day ago
US stock product cycle analysis and innovation pipeline tracking to understand future growth drivers and upcoming catalysts for stock appreciation. Our product research helps you identify companies with upcoming catalysts that could drive significant stock price appreciation in the future. We provide product pipeline analysis, innovation scoring, and catalyst tracking for comprehensive coverage. Find future winners with our comprehensive product cycle analysis and innovation tracking tools for growth investing.
👍 85
Reply
5
Dimia
Legendary User
2 days ago
This is a reminder to stay more alert.
👍 98
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.